Lestaurtinib’s antineoplastic activity converges on JAK/STAT signaling to inhibit advanced forms of therapy resistant ovarian cancer
Preprint in bioRxiv (June 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Preprint in bioRxiv (June 2024)
Article in Journal of Cellular and Molecular Medicine (March 2024)
Article in Journal of Biomolecular Structure and Dynamics (November 2023)